心内科房颤病人抗凝治疗临床效果研究.doc

心内科房颤病人抗凝治疗临床效果研究 　　[摘要] 目的 对该院心内科接收的房颤患者展开抗凝治疗方面的疗效评估。方法 整群选取2015年5月―2016年5月该院因患心房颤动而实施心内科相应治疗的患者83例，依据随机分组的原则将其划分作对比组、研究组，对比组40例以阿司匹林为主开展治疗，研究组43例施予华法林抗凝治疗，经研讨两种内科疗法的实施情况，评比患者病情归转效果。结果 研究组43例不良医疗事件脑卒中占2.33%、脑血栓占4.65%、死亡占2.33%，对比组40例不良医疗事件脑卒中占17.50%、脑血栓占20.00%、死亡占15.00%，研究组优越于对比组（P<0.05）；研究组总计3例出现用药不适症状，占比6.98%；对比组总计11例出现用药不适症状，占比27.50%。研究组用药不适症状优越于对比组，差异有统计学意义（P<0.05）。结论 以华法林实施房颤患者的抗凝性治疗，可取得较突出的用药疗效，有助减少不良医疗事件的出现几率，且服药后不适症状少，值得推荐运用。 　　[关键词] 抗凝治疗；房颤；疗效；研究 　　[中图分类号] R246 [文献标识码] A [文章编号] 1674-0742（2017）01（b）-0016-03 　　[Abstract] Objective To evaluate the clinical effect of anticoagulant therapy of patients with atrial fibrillation in the cardiovascular department. Methods Group selection 83 cases of patients with auricular fibrillation in the cardiovascular department in our hospital from May 2015 to May 2016 were group selected and randomly divided into two groups with 40 cases in each， the comparison group adopted the aspirin， while the research group adopted the Warfarin Anticoagulation Therapy， and the Transfer effect was compared after researching the implementation of the two methods. Results The adverse medical events occurred to 43 casesstroke was 2.33%， cerebral thrombosis was 4.65% and death was 2.33%， and the adverse medical events occurred to 40 cases in the control groupstroke was 17.50%， cerebral thrombosis was 20.00% and death was 15.00%， and the medication discomforts occurred to 3 cases in the research group， accounting for 6.98%， and the medication discomforts occurred to 11 cases in the comparison group， accounting for 27.50%， and the medication discomforts in the research group were better than those in the comparison group， and the difference had statistical significance（P<0.05）. Conclusion The implementation of anticoagulation therapy for patients with atrial fibrillation by using warfarin can obtain a prominent curative effect， which contributes to reducing the occurrence probability of adverse medical events with few discomforts after me